These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 25280942)
1. IL-32θ downregulates CCL5 expression through its interaction with PKCδ and STAT3. Bak Y; Kang JW; Kim MS; Park YS; Kwon T; Kim S; Hong J; Yoon DY Cell Signal; 2014 Dec; 26(12):3007-15. PubMed ID: 25280942 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association. Pham TH; Bak Y; Oh JW; Hong J; Lee S; Hong JT; Yoon DY Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010051 [TBL] [Abstract][Full Text] [Related]
3. IL-32θ negatively regulates IL-1β production through its interaction with PKCδ and the inhibition of PU.1 phosphorylation. Kim MS; Kang JW; Lee DH; Bak Y; Park YS; Song YS; Ham SY; Oh DK; Hong J; Yoon DY FEBS Lett; 2014 Aug; 588(17):2822-9. PubMed ID: 24996056 [TBL] [Abstract][Full Text] [Related]
4. IL-32α down-regulates β2 integrin (CD18) expression by suppressing PU.1 expression in myeloid cells. Kang JW; Park YS; Kim MS; Lee DH; Bak Y; Ham SY; Song YS; Hong JT; Yoon DY Cell Signal; 2014 Jul; 26(7):1514-22. PubMed ID: 24703937 [TBL] [Abstract][Full Text] [Related]
5. Interleukin (IL)-32β-mediated CCAAT/enhancer-binding protein α (C/EBPα) phosphorylation by protein kinase Cδ (PKCδ) abrogates the inhibitory effect of C/EBPα on IL-10 production. Kang JW; Park YS; Kim MS; Lee DH; Bak Y; Ham SY; Park SH; Hong JT; Yoon DY J Biol Chem; 2013 Aug; 288(33):23650-8. PubMed ID: 23814099 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer. Pham TH; Bak Y; Kwon T; Kwon SB; Oh JW; Park JH; Choi YK; Hong JT; Yoon DY Cell Commun Signal; 2019 May; 17(1):53. PubMed ID: 31126309 [TBL] [Abstract][Full Text] [Related]
7. Intracellular interaction of interleukin (IL)-32α with protein kinase Cε (PKCε ) and STAT3 protein augments IL-6 production in THP-1 promonocytic cells. Kang JW; Park YS; Lee DH; Kim JH; Kim MS; Bak Y; Hong J; Yoon DY J Biol Chem; 2012 Oct; 287(42):35556-35564. PubMed ID: 22927445 [TBL] [Abstract][Full Text] [Related]
8. IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1. Kim MS; Kang JW; Park YS; Lee DH; Bak Y; Kwon T; Yoon DY Oncotarget; 2015 Feb; 6(6):4394-405. PubMed ID: 25726525 [TBL] [Abstract][Full Text] [Related]
9. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer. Bak Y; Kwon T; Bak IS; Hong J; Yu DY; Yoon DY Oncotarget; 2016 Feb; 7(6):7307-17. PubMed ID: 26824417 [TBL] [Abstract][Full Text] [Related]
10. The CCL5/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts. Tang CH; Hsu CJ; Fong YC Arthritis Rheum; 2010 Dec; 62(12):3615-24. PubMed ID: 20862675 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 production. Kang JW; Park YS; Lee DH; Kim MS; Bak Y; Park SH; Ham SY; Yang Y; Hong JT; Yoon DY FEBS Lett; 2013 Nov; 587(23):3776-81. PubMed ID: 24396867 [TBL] [Abstract][Full Text] [Related]
12. The role of protein kinase C delta activation and STAT3 Ser727 phosphorylation in insulin-induced keratinocyte proliferation. Gartsbein M; Alt A; Hashimoto K; Nakajima K; Kuroki T; Tennenbaum T J Cell Sci; 2006 Feb; 119(Pt 3):470-81. PubMed ID: 16418226 [TBL] [Abstract][Full Text] [Related]
13. Monocyte 15-lipoxygenase expression is regulated by a novel cytosolic signaling complex with protein kinase C delta and tyrosine-phosphorylated Stat3. Bhattacharjee A; Xu B; Frank DA; Feldman GM; Cathcart MK J Immunol; 2006 Sep; 177(6):3771-81. PubMed ID: 16951338 [TBL] [Abstract][Full Text] [Related]
14. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Yang J; Liao X; Agarwal MK; Barnes L; Auron PE; Stark GR Genes Dev; 2007 Jun; 21(11):1396-408. PubMed ID: 17510282 [TBL] [Abstract][Full Text] [Related]
16. IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity. Khawar MB; Mukhtar M; Abbasi MH; Sheikh N Am J Transl Res; 2017; 9(11):4726-4737. PubMed ID: 29218075 [TBL] [Abstract][Full Text] [Related]
17. Protein kinase C-delta is involved in the inflammatory effect of IL-6 in mouse adipose cells. Wallerstedt E; Smith U; Andersson CX Diabetologia; 2010 May; 53(5):946-54. PubMed ID: 20151299 [TBL] [Abstract][Full Text] [Related]
19. Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-beta. Kim MO; Suh HS; Brosnan CF; Lee SC J Neurochem; 2004 Jul; 90(2):297-308. PubMed ID: 15228586 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-32α downregulates the activity of the B-cell CLL/lymphoma 6 protein by inhibiting protein kinase Cε-dependent SUMO-2 modification. Park YS; Kang JW; Lee DH; Kim MS; Bak Y; Yang Y; Lee HG; Hong J; Yoon DY Oncotarget; 2014 Sep; 5(18):8765-77. PubMed ID: 25245533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]